Neurological associations of COVID-19

MA Ellul, L Benjamin, B Singh, S Lant… - The Lancet …, 2020 - thelancet.com
Background The COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic …

COVID-19: A review of therapeutic strategies and vaccine candidates

V Izda, MA Jeffries, AH Sawalha - Clinical Immunology, 2021 - Elsevier
The world is engulfed by one of the most widespread and significant public health crises in
decades as COVID-19 has become among the leading causes of death internationally. The …

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

JA Hosp, A Dressing, G Blazhenets, T Bormann, A Rau… - Brain, 2021 - academic.oup.com
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
neurological symptoms increasingly moved into the focus of interest. In this prospective …

Frequent neurocognitive deficits after recovery from mild COVID-19

MS Woo, J Malsy, J Pöttgen, S Seddiq Zai… - Brain …, 2020 - academic.oup.com
Neuropsychiatric complications associated with coronavirus disease 2019 caused by the
Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies …

Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID‐19): a meta‐analysis of 27,492 patients

J Saniasiaya, MA Islam, B Abdullah - The Laryngoscope, 2021 - Wiley Online Library
Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

COVID-19 and the chemical senses: supporting players take center stage

KW Cooper, DH Brann, MC Farruggia, S Bhutani… - Neuron, 2020 - cell.com
The main neurological manifestation of COVID-19 is loss of smell or taste. The high
incidence of smell loss without significant rhinorrhea or nasal congestion suggests that …

Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic

M Sharifian-Dorche, P Huot, M Osherov, D Wen… - Journal of the …, 2020 - Elsevier
Abstract Introduction Coronavirus disease-19 (COVID-19) pandemic continues to grow all
over the world. Several studies have been performed, focusing on understanding the acute …

The impact of pre-existing comorbidities and therapeutic interventions on COVID-19

LA Callender, M Curran, SM Bates… - Frontiers in …, 2020 - frontiersin.org
Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …

Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review …

ME Hannum, VA Ramirez, SJ Lipson… - Chemical …, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …

Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences

CS von Bartheld, MM Hagen… - ACS chemical …, 2020 - ACS Publications
A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …